Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells

Experimental Hematology

Volumn 27, Issue 3, 1999, Pages 470-478

  Botzler, Claus ^a   Ellwart, Joachim ^a   Günther, Wolfgang ^b   Eißner, Günther ^a   Multhoff, Gabriele ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Bayern   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Alkyl lysophospholipid ET 18 OCH3; Antitumor immune response; Heat shock protein 70 cell surface expression; Natural killer cells

Indexed keywords

EDELFOSINE; HEAT SHOCK PROTEIN 70;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHRONIC MYELOID LEUKEMIA; CYTOLYSIS; DRUG POTENTIATION; HEAT; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTINEOPLASTIC AGENTS; BLOOD CELLS; BONE MARROW CELLS; BONE MARROW PURGING; CELL MEMBRANE; COLONY-FORMING UNITS ASSAY; FETAL BLOOD; GENE EXPRESSION REGULATION, LEUKEMIC; HEAT; HEMATOPOIETIC STEM CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; NEOPLASM PROTEINS; PHOSPHOLIPID ETHERS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0033018840     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00055-1     Document Type: Article

References (42)

1. Berdel W.E., Bausert W.R., Fink U., Rastetter J., Munder P.G. Anti-tumor action of alkyl-lysophospholipids (review). Anticancer Res. 1:1981;345.
2. Berdel W.E. Membrane-interactive lipids as experimental anticancer drugs. Br J Cancer. 64:1991;208.
3. Berdel W.E. Ether lipids and derivatives as investigational anticancer drugs. Oncology. 13:1990;245.
4. Berdel W.E., Greiner E., Fink U., Zanker K.S., Stavrou D., Trappe A., Fahlbusch R., Reichert A., Rastetter J. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells. Oncology. 41:1984;140.
5. Dive C., Watson J.V., Workman P. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells. Cancer Res. 51:1991;799.
6. van-Blitterswijk W.J., Hilkmann H., Storme G.A. Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids. 22:1987;820.
7. Chabot M.C., Wykle R.L., Modest E.J., Daniel L.W. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Cancer Res. 49:1989;4441.
8. Diomede L., Bizzi A., Magistrelli A., Modest E.J., Salmona M., Noseda A. Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity. Int J Cancer. 46:1990;341.
9. Vogler W.R., Olson A.C., Okamoto S., Shoji M., Raynor R.L., Kuo J.F., Berdel W.E., Eibl H., Hajdu J., Nomura H. Comparison of selective cytotoxicity of alkyl lysophospholipids. Lipids. 26:1991;1418.
10. Verdonck L.F., Witteveen E.O., van-Heugten H.G., Rozemuller E., Rijksen G. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid. Cancer Res. 50:1990;4020.
11. Yamazaki T., Sieber F. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells. implications for the extracorporeal purging of autologous hematopoietic stem cells Bone Marrow Transplant. 19:1997;113.
12. Tidwell T., Guzman G., Vogler W.R. The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562. Blood. 57:1981;794.
13. Heesbeen E.C., Rijksen G., van-Heugten H.G., Verdonck L.F. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3. Leuk Res. 19:1995;417.
14. Brenner M.K., Rill D.R., Moen R.C., Krance R.A., Mirro J.J., Anderson W.F., Ihle J.N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet. 341:1993;85.
15. Okamoto S., Olson A.C., Berdel W.E., Vogler W.R. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia. Blood. 72:1988;1777.
16. Fujiwara K., Modest E.J., Welander C.E., Wallen C.A. Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells. Cancer Res. 49:1989;6285.
17. Fujiwara K., Modest E.J., Wallen C.A. Cell kill and cytostasis by ET-18-OCH3 and heat. Anticancer Res. 15:1995;1333.
18. Botzler C., Kolb H.J., Issels R.D., Multhoff G. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells. Int J Cancer. 65:1996;633.
19. - large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells. Blood. 86:1995;1374.
20. Bauer H.C., Hurtenbach U. Murine cortical brain cells are autoantigenic from a distinct developmental stage onwards. J. Neuroimmunol. 12:1986;1.
21. MacDonald H.R., Engers H.D., Cerottini J.C., Brunner K.T. Generation of cytotoxic T lymphocytes in vitro. II. Effect of repeated exposure to alloantigens on the cytotroxic activity of long-term mixed leukocyte cultures. J Exp Med. 140:1974;133.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. procedure and some applications Proc Natl Acad Sci U S A. 76:1979;4350.
24. Vogler W.R., Somberg L.B., Glasser L. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids. Exp Hematol. 15:1987;360.
25. Glasser L., Dalton W.S., Fiederlein R.L., Cook P., Powis G., Vogler W.R. Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipid. Exp Hematol. 24:1996;253.
26. Botzler C., Issels R., Multhoff G. Heat-shock protein 72 cell-surface expression on human lung carcinoma cells in associated with an increased sensitivity to lysis mediated by adherent natural killer cells. Cancer Immunol Immunother. 43:1996;226.
27. Multhoff G., Botzler C., Jennen L., Schmidt J., Ellwart J., Issels R. Heat shock protein 72 on tumor cells. A recognition structure for natural killer cells. J Immunol. 158:1997;4341.
28. Kosano H., Takatani O. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. Cancer Res. 48:1988;6033.
29. Kosano H., Yasutomo Y., Kugai N., Nagata N., Inagaki H., Tanaka S., Takatani O. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid. Cancer Res. 50:1990;3172.
30. Hoffman D.R., Hoffman L.H., Snyder F. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Cancer Res. 46:1986;5803.
31. Small G.W., Strum J.C., Daniel L.W. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine. Lipids. 32:1997;715.
32. Mollinedo F., Fernandez-Luna J.L., Gajate C., Martin-Martin B., Benito A., Martinez-Dalmau R., Modolell M. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine). molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L) Cancer Res. 57:1997;1320.
33. Principe P., Sidoti C., Coulomb H., Broquet C., Braquet P. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids. Cancer Detect Prev. 18:1994;393.
34. Daniel L.W., Civoli F., Rogers M.A., Smitherman P.K., Raju P.A., Roederer M. ET-18-OCH3 inhibits nuclear factor-KB activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-α or interleukin 1α Cancer Res. 55:1995;4844.
35. Multhoff G. Heat shock protein 72 (HSP72), a hypertherima-inducible immunogenic determinant on leukemic K562 and Ewing's Sarcoma cells. Int J Hyperthermia. 13:1997;39.
36. Udono H., Srivastava P.K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol. 152:1994;5398.
37. Suto R., Srivastava P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1995;1585.
38. Udono H., Srivastava P.K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 178:1993;1391.
39. Fuller K.J., Issels R.D., Slosman D.O., Guillet J.-G., Soussi T., Polla B.S. Cancer and the heat shock response. Eur J Cancer. 30:1994;1884.
40. Yatvin M. The influence of membrane lipid composition and procaine on hyperthermic death of mice cells. Int J Radiat Biol. 32:1977;513.
41. Torok Z., Demel R.A., Leenhouts J.M., de-Kruijff B. Presequence-mediated intermembrane contact formation and lipid flow. A model membrane study. Biochemistry. 33:1994;5589.
42. Gorin N.C. Marrow purging for autologous bone marrow transplantation and its role in acute myelocytic leukemia. European Cooperative Group for Bone Marrow Transplantation. (EBMT). Leukemia. 6(suppl 2):1992;96.